You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mRNA vaccine

Showing 1 - 25 of 8,824
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)

Not yet recruiting
  • Influenza, Human
  • sa-mRNA vaccine Dose 1
  • +4 more
  • (no location specified)
Sep 7, 2023

SARS-CoV-2 Infection Trial in Hangzhou (Placebo, COVID-19 Vaccine (Vero Cell) ,Inactivated, COVID-19 mRNA Vaccine (ZSVG-02-O) 10

Recruiting
  • SARS-CoV-2 Infection
  • Placebo
  • +4 more
  • Hangzhou, Zhejiang, China
    Shulan (Hangzhou) Hospital
Nov 7, 2023

SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 mRNA vaccine (RBMRNA)
  • CoronaVac®
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023

Vaccination; Infection, COVID-19 Trial (Comirnaty)

Not yet recruiting
  • Vaccination; Infection
  • COVID-19
  • Comirnaty
  • (no location specified)
Aug 4, 2023

Safety of 50 ug of ChulaCov19-BNA159 mRNA Vaccine, Tolerability of 50 ug of ChulaCov19-BNA159 mRNA Vaccine, Immune Response of

Not yet recruiting
  • Safety of 25 ug of ChulaCov19-BNA159 mRNA Vaccine
  • +6 more
  • ChulaCov19 BNA159 mRNA vaccine
  • Bangkok, Thailand
  • +1 more
Nov 30, 2022

SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19 mRNA Vaccine (ZSVG-02-O)
  • COVID-19 Vaccine (Vero Cell) ,Inactivated
  • Dengfeng, Henan, China
  • +1 more
Nov 6, 2023

COVID-19 Trial in Paris (Lymph node aspiration / Blood sampling)

Recruiting
  • COVID-19
  • Lymph node aspiration / Blood sampling
  • Paris, France
    GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 19, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • Saline
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta

Not yet recruiting
  • Vaccine Reaction
  • COVID-19
  • Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
  • VidPrevtyn® Beta vaccine (Sanofi/GSK)
  • Paris, France
    CIC 1417 Cochin-Pasteur
Feb 28, 2023

SARS-CoV-2 Trial (SARS-CoV-2 mRNA Vaccine, Bivalent Low dose, SARS-CoV-2 mRNA Vaccine, Bivalent High dose, Placebo)

Recruiting
  • SARS-CoV-2
  • SARS-CoV-2 mRNA Vaccine, Bivalent Low dose
  • +2 more
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Jan 3, 2023

SARS-CoV-2 Trial (SARS-CoV-2 variant mRNA vaccine low dose, SARS-CoV-2 variant mRNA vaccine high dose)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 variant mRNA vaccine low dose
  • SARS-CoV-2 variant mRNA vaccine high dose
  • (no location specified)
Oct 30, 2022

Advanced Malignant Solid Tumors Trial (Neoantigen mRNA Personalised Cancer vaccine)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Neoantigen mRNA Personalised Cancer vaccine
  • (no location specified)
Jul 16, 2023

SARS-CoV-2 Trial in Bengbu (COVID-19 Variant (Omicron BA.5) mRNA Vaccine Low dose, COVID-19 Variant (Omicron BA.5) mRNA Vaccine

Recruiting
  • SARS-CoV-2
  • COVID-19 Variant (Omicron BA.5) mRNA Vaccine Low dose
  • +2 more
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Jan 3, 2023

Glioblastoma Trial in Belgium, Germany, Netherlands (CV09050101 mRNA vaccine (CVGBM) 12 µg, CV09050101 mRNA vaccine (CVGBM) 25

Recruiting
  • Glioblastoma
  • CV09050101 mRNA vaccine (CVGBM) 12 μg
  • +5 more
  • Woluwe-Saint-Lambert, Brussels, Belgium
  • +14 more
Jul 12, 2023

SARS-CoV-2 Trial (SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine high

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose
  • +2 more
  • (no location specified)
Dec 1, 2022

SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose
  • +2 more
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Jan 3, 2023

Posto Perative Hepatocellular Carcinoma Trial (Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I

Not yet recruiting
  • Posto Perative Hepatocellular Carcinoma
  • Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I njection
  • (no location specified)
Feb 27, 2023

Malignant Tumors Trial in Chengdu (EBV mRNA vaccine)

Recruiting
  • Malignant Tumors
  • EBV mRNA vaccine
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Jan 27, 2023

Liver Cancer, Hepatocellular Carcinoma Trial in Chengdu (HBV mRNA vaccine)

Recruiting
  • Liver Cancer
  • Hepatocellular Carcinoma
  • HBV mRNA vaccine
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Feb 12, 2023

SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine, Saline solution)

Recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine
  • Saline solution
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Feb 26, 2023

SARS-CoV-2 Trial in Chengdu (RBMRNA-176, Placebo)

Active, not recruiting
  • SARS-CoV-2
  • RBMRNA-176
  • Placebo
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)

Recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
  • 0.9% sodium chloride solution
  • Islamabad, Pakistan
    Sindh Infectious Diseases Hospital & Research Center Dow Univers
Apr 16, 2023

COVID-19 Trial in Kunming (RQ3013, RQ3025, RQ3027)

Recruiting
  • COVID-19
  • RQ3013
  • +2 more
  • Kunming, Yunnan, China
    The Affiliated Hospital of Yunnan University
Jun 22, 2023